000650 仁和药业
已收盘 11-20 15:00:00
资讯
新帖
简况
股市必读:仁和药业(000650)11月18日董秘有最新回复
证券之星 · 11-19
股市必读:仁和药业(000650)11月18日董秘有最新回复
股市必读:仁和药业新发布《关于公司产品通过谈判、竞价首次纳入国家医保目录的公告》
证券之星 · 11-18
股市必读:仁和药业新发布《关于公司产品通过谈判、竞价首次纳入国家医保目录的公告》
股市必读:仁和药业新发布《关于公司产品通过谈判、竞价首次纳入国家医保目录的公告》
证券之星 · 11-17
股市必读:仁和药业新发布《关于公司产品通过谈判、竞价首次纳入国家医保目录的公告》
仁和药业(000650.SZ):二冬汤颗粒、清肺汤颗粒首次纳入国家医保目录
智通财经 · 11-16
仁和药业(000650.SZ):二冬汤颗粒、清肺汤颗粒首次纳入国家医保目录
仁和药业:公司已披露相关公告,公告编号2026-046
证券之星 · 11-16
仁和药业:公司已披露相关公告,公告编号2026-046
仁和药业:截至2026年11月10日,大约8.85万户左右
证券之星 · 11-16
仁和药业:截至2026年11月10日,大约8.85万户左右
仁和药业:公司第二增长曲线是除传统医药或大健康板块外创新业务
证券之星 · 11-16
仁和药业:公司第二增长曲线是除传统医药或大健康板块外创新业务
股市必读:仁和药业(000650)11月13日董秘有最新回复
证券之星 · 11-16
股市必读:仁和药业(000650)11月13日董秘有最新回复
股市必读:仁和药业(000650)股东户数8.86万户,较上期减少0.45%
证券之星 · 11-09
股市必读:仁和药业(000650)股东户数8.86万户,较上期减少0.45%
仁和药业:截至2026年10月30日,大约8.86万户左右
证券之星 · 11-06
仁和药业:截至2026年10月30日,大约8.86万户左右
股市必读:仁和药业新发布《公司2026年第三季度权益分派实施公告》
证券之星 · 11-06
股市必读:仁和药业新发布《公司2026年第三季度权益分派实施公告》
股市必读:仁和药业新发布《公司2026年第三季度权益分派实施公告》
证券之星 · 11-05
股市必读:仁和药业新发布《公司2026年第三季度权益分派实施公告》
股市必读:仁和药业(000650)10月30日董秘有最新回复
证券之星 · 11-02
股市必读:仁和药业(000650)10月30日董秘有最新回复
仁和药业:公司第二增长曲线是除传统医药或大健康板块外创新业务
证券之星 · 10-30
仁和药业:公司第二增长曲线是除传统医药或大健康板块外创新业务
股市必读:仁和药业(000650)10月29日董秘有最新回复
证券之星 · 10-30
股市必读:仁和药业(000650)10月29日董秘有最新回复
仁和药业:上述对应持股比例分别为1.5365%、0.76%、16.65%和20%
证券之星 · 10-29
仁和药业:上述对应持股比例分别为1.5365%、0.76%、16.65%和20%
仁和药业(000650)2026年三季报简析:净利润同比下降1.84%
证券之星 · 10-28
仁和药业(000650)2026年三季报简析:净利润同比下降1.84%
仁和药业:收购江西中进药业有限公司少数股东股权
证券之星 · 10-27
仁和药业:收购江西中进药业有限公司少数股东股权
仁和药业(000650)披露2026年三季度报告,10月27日股价下跌2.32%
证券之星 · 10-27
仁和药业(000650)披露2026年三季度报告,10月27日股价下跌2.32%
仁和药业(000650)10月20日股东户数8.9万户,较上期增加0.34%
证券之星 · 10-27
仁和药业(000650)10月20日股东户数8.9万户,较上期增加0.34%
加载更多
公司概况
公司名称:
仁和药业股份有限公司
所属行业:
医药制造业
上市日期:
1996-12-10
主营业务:
仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是药品、健康相关产品。
发行价格:
6.26
{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":4.75,"timestamp":1795158207000,"preClose":4.85,"halted":0,"volume":16666462,"delay":0,"changeRate":-0.0206,"floatShares":1331000000,"shares":1400000000,"eps":0.276,"marketStatus":"已收盘","change":-0.1,"latestTime":"11-20 15:00:00","open":4.81,"high":4.83,"low":4.71,"amount":79259100,"amplitude":0.0247,"askPrice":4.77,"askSize":937,"bidPrice":4.75,"bidSize":271,"shortable":0,"etf":0,"ttmEps":0.276,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":4.85,"symbolType":"stock","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":5.34,"lowLimit":4.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"isCdr":false,"pbRate":1.06,"roa":"--","peRate":17.210145,"roe":"5.79%","epsLYR":0.28,"committee":0.359902,"marketValue":6650000000,"turnoverRate":0.0125,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-23。","floatMarketCap":6324000000},"requestUrl":"/m/hq/s/000650","defaultTab":"news","newsList":[{"id":"2684913033","title":"股市必读:仁和药业(000650)11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2684913033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684913033?lang=zh_cn&edition=full","pubTime":"2026-11-19 02:28","pubTimestamp":1795026494,"startTime":"0","endTime":"0","summary":"截至2026年11月18日收盘,仁和药业报收于4.9元,下跌0.61%,换手率0.95%,成交量12.6万手,成交额6214.38万元。董秘最新回复投资者: 您好,公司年度报告反映出员工总量和人均营收呈下降态势,今后一年全局招聘数量是否会调整?公司人员规模及效率指标变化受多重因素影响。关于年报信息披露内容,公司将严格遵循相关法律法规要求,合理规划披露事项。当日关注点交易信息汇总:11月18日主力资金净流入333.98万元,占总成交额5.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111900001607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000650","BK0097","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684933250","title":"股市必读:仁和药业新发布《关于公司产品通过谈判、竞价首次纳入国家医保目录的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2684933250","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684933250?lang=zh_cn&edition=full","pubTime":"2026-11-18 03:32","pubTimestamp":1794943931,"startTime":"0","endTime":"0","summary":"截至2026年11月17日收盘,仁和药业报收于4.93元,上涨0.2%,换手率0.98%,成交量13.01万手,成交额6437.18万元。公司公告汇总关于公司产品通过谈判、竞价首次纳入国家医保目录的公告仁和药业股份有限公司公告,其产品二冬汤颗粒、清肺汤颗粒通过竞价、谈判首次纳入《国家基本医疗保险、生育保险和工伤保险药品目录》。两药品协议有效期自2027年1月1日至2028年12月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800003102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684644344","title":"股市必读:仁和药业新发布《关于公司产品通过谈判、竞价首次纳入国家医保目录的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2684644344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684644344?lang=zh_cn&edition=full","pubTime":"2026-11-17 02:23","pubTimestamp":1794853389,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动截至2026年11月10日公司股东户数为8.85万户,较10月30日减少100.0户,减幅为0.11%。公司公告汇总关于公司产品通过谈判、竞价首次纳入国家医保目录的公告仁和药业股份有限公司公告,其产品二冬汤颗粒、清肺汤颗粒通过竞价、谈判首次纳入《国家基本医疗保险、生育保险和工伤保险药品目录》。董秘最新回复投资者: 你好,仁和集团近日披露贵公司旗下的二冬汤颗粒与清肺汤颗粒进入国家医保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700001417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683869935","title":"仁和药业(000650.SZ):二冬汤颗粒、清肺汤颗粒首次纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2683869935","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683869935?lang=zh_cn&edition=full","pubTime":"2026-11-16 16:01","pubTimestamp":1794816098,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仁和药业(000650.SZ)发布公告,公司古代经典名方药品二冬汤颗粒、清肺汤颗粒通过竞价、谈判首次纳入《国家基本医疗保险、生育保险和工伤保险药品目录(2026年)》(简称“《国家医保目录》(2026版)”)。协议有效期为2027年1月1日至2028年12月31日。公司药品被纳入《国家医保目录》(2026版)将有利于促进市场开拓,对公司未来销售增长及长期经营发展具有积极作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"仁和药业(000650.SZ):二冬汤颗粒、清肺汤颗粒首次纳入国家医保目录","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0097","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683696265","title":"仁和药业:公司已披露相关公告,公告编号2026-046","url":"https://stock-news.laohu8.com/highlight/detail?id=2683696265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683696265?lang=zh_cn&edition=full","pubTime":"2026-11-16 15:42","pubTimestamp":1794814939,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)11月16日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,仁和集团近日披露贵公司旗下的二冬汤颗粒与清肺汤颗粒进入国家医保。该信息为何不在上市公司公告发布,是否说明该事项对公司经营没有重大影响?仁和药业回复:尊敬的投资者,您好!公司已披露相关公告,公告编号2026-046,请查阅。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600016301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000650","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683693722","title":"仁和药业:截至2026年11月10日,大约8.85万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2683693722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683693722?lang=zh_cn&edition=full","pubTime":"2026-11-16 15:03","pubTimestamp":1794812594,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)11月16日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截止2026年11月10日的股东户数是多少?谢谢仁和药业回复:谢谢您的关注,截至2026年11月10日,大约8.85万户左右。具体数据,根据相关法规,请您先向公司证券部提交股东身份证明,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600014639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683069372","title":"仁和药业:公司第二增长曲线是除传统医药或大健康板块外创新业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2683069372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683069372?lang=zh_cn&edition=full","pubTime":"2026-11-16 15:03","pubTimestamp":1794812594,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)11月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!贵公司的第二增长曲线是否为与必爱智能合作开发智能穿戴产品?仁和药业回复:尊敬的投资者,您好!公司第二增长曲线是除传统医药或大健康板块外创新业务。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600014641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1515","BK0097","BK1161","BK0188","159938","BK0239","09939","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683165761","title":"股市必读:仁和药业(000650)11月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2683165761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683165761?lang=zh_cn&edition=full","pubTime":"2026-11-16 02:42","pubTimestamp":1794768131,"startTime":"0","endTime":"0","summary":"截至2026年11月13日收盘,仁和药业报收于4.89元,下跌1.21%,换手率1.39%,成交量18.54万手,成交额9121.19万元。董秘最新回复投资者: 你好!目前贵公司的股票价格没有显示代表贵公司真实价值,握有41亿元资金!我们仅代表广大中小股东,呼吁董事会,为了鼓励8万8千多广大中小股东和4千9百多员工的信心,适当提高2026年年底的分红比例!当日关注点交易信息汇总:11月13日主力资金净流出620.33万元,占总成交额6.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600000908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0188","BK0097","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682826202","title":"股市必读:仁和药业(000650)股东户数8.86万户,较上期减少0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682826202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682826202?lang=zh_cn&edition=full","pubTime":"2026-11-09 04:15","pubTimestamp":1794168913,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘,仁和药业报收于5.12元,下跌0.97%,换手率0.84%,成交量11.17万手,成交额5725.6万元。股本股东变化:截至2026年10月30日,仁和药业股东户数为8.86万户,较10月20日减少400户,减幅0.45%。董秘最新回复投资者: 请问公司最新一期的股东户数是多少?谢谢董秘: 谢谢您的关注,截至2026年10月30日,大约8.86万户左右。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900001214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681833282","title":"仁和药业:截至2026年10月30日,大约8.86万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2681833282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681833282?lang=zh_cn&edition=full","pubTime":"2026-11-06 11:36","pubTimestamp":1793936195,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司最新一期的股东户数是多少?谢谢仁和药业回复:谢谢您的关注,截至2026年10月30日,大约8.86万户左右。具体数据,根据相关法规,请您先向公司证券部提交股东身份证明,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600014874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681006640","title":"股市必读:仁和药业新发布《公司2026年第三季度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681006640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681006640?lang=zh_cn&edition=full","pubTime":"2026-11-06 02:39","pubTimestamp":1793903950,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘,仁和药业报收于5.17元,上涨0.39%,换手率0.96%,成交量12.83万手,成交额6608.84万元。公司公告汇总:仁和药业发布2026年第三季度权益分派实施公告,以剔除已回购股份后的1,382,238,184股为基数,每10股派0.506402元现金(含税),股权登记日为2026年11月12日,除权除息日为2026年11月13日,实际现金分红总额69,996,818.08元(含税)。现金红利由中国结算深圳分公司代派,部分股东由公司自行派发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600002430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","BK0188","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681061622","title":"股市必读:仁和药业新发布《公司2026年第三季度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681061622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681061622?lang=zh_cn&edition=full","pubTime":"2026-11-05 02:36","pubTimestamp":1793817373,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘,仁和药业报收于5.15元,上涨0.39%,换手率1.55%,成交量20.65万手,成交额1.07亿元。公司公告汇总:仁和药业发布2026年第三季度权益分派实施公告,以1,382,238,184股为基数,每10股派0.506402元现金(含税),股权登记日为2026年11月12日,除权除息日为2026年11月13日,实际分红总额69,996,818.08元(含税)。现金红利由中国结算深圳分公司代派,部分股东由公司自行派发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500004473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680789615","title":"股市必读:仁和药业(000650)10月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680789615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680789615?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:31","pubTimestamp":1793583110,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,仁和药业报收于5.03元,上涨1.0%,换手率1.43%,成交量18.98万手,成交额9551.49万元。董秘最新回复投资者: 你好!当日关注点交易信息汇总:10月30日主力资金净流出322.67万元,占总成交额3.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200004215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0188","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679267821","title":"仁和药业:公司第二增长曲线是除传统医药或大健康板块外创新业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2679267821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679267821?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:42","pubTimestamp":1793346131,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!贵公司在互动平台回复的第二增长曲线是什么?是否是对外股权投资?仁和药业回复:尊敬的投资者,您好!公司第二增长曲线是除传统医药或大健康板块外创新业务。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000034420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0097","BK0188","BK1515","000650","BK0239","BK1574","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679230311","title":"股市必读:仁和药业(000650)10月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2679230311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679230311?lang=zh_cn&edition=full","pubTime":"2026-10-30 06:17","pubTimestamp":1793312261,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘,仁和药业报收于4.98元,下跌0.8%,换手率1.12%,成交量14.9万手,成交额7432.75万元。董秘最新回复投资者: 董秘您好!截止目前贵公司对北京洛必德、睿晶半导体、南京招银现代、杭州飞镖夏焱的持股比例各是多少?上述对应持股比例分别为1.5365%、0.76%、16.65%和20%,年度报告里面有相关内容。当日关注点交易信息汇总:10月29日主力资金净流出229.88万元,占总成交额3.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000010109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679579441","title":"仁和药业:上述对应持股比例分别为1.5365%、0.76%、16.65%和20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679579441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679579441?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:15","pubTimestamp":1793236511,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!截止目前贵公司对北京洛必德、睿晶半导体、南京招银现代、杭州飞镖夏焱的持股比例各是多少?对外投资收益占贵公司总收益的比例是多少?仁和药业回复:尊敬的投资者,您好!上述对应持股比例分别为1.5365%、0.76%、16.65%和20%,年度报告里面有相关内容。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900016051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678460316","title":"仁和药业(000650)2026年三季报简析:净利润同比下降1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678460316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678460316?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:20","pubTimestamp":1793190028,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期仁和药业发布2026年三季报。根据财报显示,仁和药业净利润同比下降1.84%。截至本报告期末,公司营业总收入27.92亿元,同比下降1.48%,归母净利润3.72亿元,同比下降1.84%。按单季度数据看,第三季度营业总收入7.01亿元,同比下降18.37%,第三季度归母净利润8022.22万元,同比下降9.57%。财报体检工具显示:建议关注公司应收账款状况本文数据来源于仁和药业2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800047081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678170579","title":"仁和药业:收购江西中进药业有限公司少数股东股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2678170579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678170579?lang=zh_cn&edition=full","pubTime":"2026-10-27 20:52","pubTimestamp":1793105544,"startTime":"0","endTime":"0","summary":"本次股权收购标的为江西中进药业有限公司,该公司是已纳入公司合并报表范围的控股孙公司,收购不会导致合并报表范围发生变化。本次收购少数股东股权有利于进一步加强整体经营管理,提升其经营决策效率,符合公司整体发展战略规划。收购所需资金为公司自有或自筹资金,不会对公司财务及经营状况产生重大不利影响,不会损害公司及股东特别是中小股东的权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700042108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678007179","title":"仁和药业(000650)披露2026年三季度报告,10月27日股价下跌2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678007179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678007179?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:17","pubTimestamp":1793099848,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘,仁和药业报收于5.05元,较前一交易日下跌2.32%,最新总市值为70.7亿元。仁和药业于2026年10月27日披露《2026年三季度报告》。报告显示,本报告期营业收入700,710,999.27元,同比下降18.37%;归属于上市公司股东的净利润80,222,169.09元,同比下降9.57%。年初至报告期末营业收入2,791,652,026.30元,同比下降1.48%;归属于上市公司股东的净利润372,171,309.37元,同比下降1.84%。总资产7,770,304,822.80元,较上年度末增长0.45%;归属于上市公司股东的所有者权益6,380,058,723.62元,较上年度末增长1.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700037034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678173283","title":"仁和药业(000650)10月20日股东户数8.9万户,较上期增加0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678173283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678173283?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:37","pubTimestamp":1793097473,"startTime":"0","endTime":"0","summary":"证券之星消息,近日仁和药业披露,截至2026年10月20日公司股东户数为8.9万户,较10月9日增加300.0户,增幅为0.34%。在中药行业个股中,仁和药业股东户数高于行业平均水平,截至10月20日,中药行业平均股东户数为5.24万户。从股价来看,2026年10月9日至2026年10月20日,仁和药业区间跌幅为3.02%,在此期间股东户数增加300.0户,增幅为0.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700034609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795336189622,"stockEarnings":[{"period":"1week","weight":-0.0286},{"period":"1month","weight":-0.0629},{"period":"3month","weight":-0.1065},{"period":"6month","weight":-0.0839},{"period":"1year","weight":-0.1854},{"period":"ytd","weight":-0.1276}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仁和药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88500人(较上一季度减少0.11%)","perCapita":"15043股","listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","registeredCapital":"139993万元","survey":" 仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是药品、健康相关产品。","listedPrice":6.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}